Table 5.
Other outcomes of children in probiotics versus probiotics plus zinc groups
| Outcome | Study groups at 2 weeks no (%) |
MD (95% CI) | RR (95% CI) | P value | |
|---|---|---|---|---|---|
| Probiotics (n=51) | Probiotics plus zinc (n=50) | ||||
| Receipt of intravenous fluids | 1.000b) | ||||
| No | 50 (98.04) | 50 (100) | 1.02 (0.07–15.84) | ||
| Yes | 1 (1.96) | 0 (0) | - | ||
| Hospital admission | 1.000b) | ||||
| No | 50 (98.04) | 50 (100) | 1.02 (0.07–15.84) | ||
| Yes | 1 (1.96) | 0 (0) | - | ||
| Repetition of Emergency Department visitc) | 0.495b) | ||||
| No | 51 (100) | 49 (98.00) | 1.02 (0.07–15.84) | ||
| Yes | 0 (0) | 1 (2.00) | - | ||
| Healing day | 2.00±0.0 | 1.34±0.81 | -0.66 (-0.89 to -0.44) | <0.001a) | |
| Healing duration (day) | - | 0.031 | |||
| 1–2 | 36 (70.59) | 44 (88.00) | 0.41 (0.17–0.97) | ||
| 3–7 | 15 (29.41) | 6 (12.00) | |||
Values are presented as number (%) or mean±standard deviation.
RR, risk ratio; CI, confidence interval; MD, mean difference.
a)
Independent t test.
b)
Pearson chi-square test.
c)
Repeat visits to the study clinicians.
Boldface indicates a statistically significant difference with P<0.05.